tiprankstipranks
Monte Rosa Therapeutics presents preclinical data on CDK2 degrader
PremiumThe FlyMonte Rosa Therapeutics presents preclinical data on CDK2 degrader
2M ago
Monte Rosa Highlights Promising Results in Cancer Study
Premium
Company Announcements
Monte Rosa Highlights Promising Results in Cancer Study
2M ago
Monte Rosa Therapeutics provides development progress on ongoing MRT-2359 study
Premium
The Fly
Monte Rosa Therapeutics provides development progress on ongoing MRT-2359 study
2M ago
Monte Rosa Enters Global License Agreement with Novartis
PremiumCompany AnnouncementsMonte Rosa Enters Global License Agreement with Novartis
3M ago
Monte Rosa announces global license agreement with Novartis
Premium
The Fly
Monte Rosa announces global license agreement with Novartis
3M ago
Monte Rosa Therapeutics presents preclinical data at ENA 2024
Premium
The Fly
Monte Rosa Therapeutics presents preclinical data at ENA 2024
3M ago
Monte Rosa Therapeutics announces FDA acceptance of IND for MRT-6160
PremiumThe FlyMonte Rosa Therapeutics announces FDA acceptance of IND for MRT-6160
6M ago
Monte Rosa Therapeutics reports Q2 EPS (43c), consensus (54c)
Premium
The Fly
Monte Rosa Therapeutics reports Q2 EPS (43c), consensus (54c)
6M ago
These 2 ‘Strong Buy’ Penny Stocks Could Jump at Least 300%, Says Piper Sandler
Premium
Stock Analysis & Ideas
These 2 ‘Strong Buy’ Penny Stocks Could Jump at Least 300%, Says Piper Sandler
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100